IL-6 and IL-8 have been suggested as potential biomarkers for early NEC detection or risk stratification in several cohorts, and with variation over the periods of observation, the disease stages and underlying sepsis probably vary [13]. The gene discussed is IL6; the disease is necrotizing enterocolitis.